Intracellularly Expressed Single-Domain Antibody against p15 Matrix Protein Prevents the Production of Porcine Retroviruses

Journal of Virology

Volumn 77, Issue 22, 2003, Pages 12132-12139

  Dekker, Sylvia ^a   Toussaint, Wendy ^a   Panayotou, George ^b   De Wit, Ton ^a   Visser, Pim ^a   Grosveld, Frank ^a   Drabek, Dubravka ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOXYCYCLINE; EPITOPE; GAG PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; POLYCLONAL ANTIBODY; POLYPROTEIN; RNA; VIRUS ANTIBODY; VIRUS PROTEIN;

ANTIGEN SPECIFICITY; ARTICLE; CELL CULTURE; GENE EXPRESSION; INFECTION RISK; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROVIRUS; VIRUS PARTICLE; VIRUS TRANSMISSION; XENOTRANSPLANTATION; ZOONOSIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ENDOGENOUS RETROVIRUSES; EPITOPE MAPPING; GENE PRODUCTS, GAG; HUMANS; IMMUNE SERA; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; MOLECULAR SEQUENCE DATA; RETROVIRIDAE INFECTIONS; SWINE; TRANSPLANTATION, HETEROLOGOUS; VIRAL MATRIX PROTEINS; VIRUS REPLICATION;

EID: 0242300184     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.22.12132-12139.2003     Document Type: Article

References (42)

1. Butler, D. 2002. Xenotransplant experts express caution over knockout piglets. Nature 415:103-104.
2. Cozzi, E., A. W. Tucker, G. A. Langford, G. Pino-Chavez, L. Wright, M. J. O'Connell, V. J. Young, R. Lancaster, M. McLaughlin, K. Hunt, M. C. Bordin, and D. J. White. 1997. Characterization of pigs transgenic for human decay-accelerating factor. Transplantation 64:1383-1392.
3. Cozzi, E., and D. J. G. White. 1995. The generation of transgenic pigs as potential organ donors for humans. Nat. Med. 1:964-966.
4. Cunningham, D. A., C. Herring, X. M. Fernandez-Suarez, A. J. Whittam, K. Paradis, and G. A. Langford. 2001. Analysis of patients treated with living pig tissue for evidence of infection by porcine endogenous retroviruses. Trends Cardiovasc. Med. 11:190-196.
5. Czauderna, F., N. Fisher, K. Boller, R. Kurth, and R. R. Tönjes. 2000. Establishment and characterization of molecular clones of porcine endogenous retroviruses replicating on human cells. J. Virol. 74:4028-4038.
6. Dai, Y., T. D. Vaught, J. Boone, S. Chen, C. J. Phelps, S. Ball, J. A. Monahan, P. M. Jobst, K. J. McCreath, A. E. Lamborn, J. L. Cowell-Lucero, K. D. Wells, A. Colman, I. A. Polejaeva, and D. L. Ayares. 2002. Targeted disruption of the α-1, 3-galactosyltransferase gene in cloned pigs. Nat. Biotechnol. 20:251-255.
7. Deng, Y. M., B. E. Tuch, and W. D. Rowlinson. 2000. Transmission of porcine endogenous retroviruses in severe combined immunodeficient mice xenotransplanted with fetal porcine pancreatic cells. Transplantation 70:1010-1016.
8. Denner, J. 1998. Immunosuppression by retroviruses: implications for xenotransplantation. Ann. N. Y. Acad. Sci. 862:75-86.
9. Dinsmore, J. H., C. Manhart, R. Raineri, D. B. Jacoby, and A. Moore. 2000. No evidence for infection of human cells with porcine endogenous retrovirus (PERV) after exposure to porcine fetal neuronal cells. Transplantation 70: 1382-1389.
10. Fiebig, U., O. Stephan, R. Kurth, and J. Denner. 2003. Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? Virology 307:406-413.
11. Fraisier, C., D. A. Abraham, M. van Ooijen, V. Cunliffe, A. Irvine, R. Craig, and E. A. Dzierzak. 1998. Inhibition of Tat-mediated transactivation and HIV replication with Tat mutant and repressor domain fusion proteins. Gene Ther. 5:946-954.
12. Freed, E. O. 1998. HIV-1 Gag proteins: diverse functions in the virus life cycle. Virology 251:1-15.
13. Geuze, H. J., J. W. Slot, P. A. van der Ley, and R. C. T. Scheffer. 1981. Use of colloidal gold particles in double-labeling immunoelectron microscopy of ultrathin frozen tissue sections. J. Cell Biol. 89:653-665.
14. Herring, C., D. A. Cunningham, A. J. Whittam, X. M. Fernandez-Suarez, and G. A. Langford. 2001. Monitoring xenotransplant recipients for infection by PERV. Clin. Biochem. 34:23-27.
15. Hoogenboom, H. R., A. D. Griffiths, K. S. Johnson, D. J. Chriswell, P. Hudson, and G. Winter. 1991. Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains. Nucleic Acids Res. 19:4133-4137.
16. Kazemier, B., H. de Haard, P. Boender, B. van Gemen, and H. Hoogenboom. 1996. Determination of active single-chain antibody concentrations in crude periplasmic fractions. J. Immunol. Methods 194:201-209.
17. Lai, L., D. Kolber-Simonds, K. Park, H. Cheong, J. L. Greenstein, G. Im, M. Samuel, A. Bonk, A. Rieke, B. N. Day, C. N. Murphy, D. B. Carter, R. J. Hawley, and R. S. Prather. 2002. Production of α-1, 3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 295:1089-1092.
18. Le Tissier, P., J. P. Stoye, Y. Takeuchi, C. Patience, and R. A. Weiss. 1997. Two sets of human-tropic pig retroviruses. Nature 389:681-682.
19. Levin, R., A. M. Mhashilkar, T. Dorfman, A. Bukovsky, C. Zani, J. Bagley, J. Hinkula, M. Niedrig, J. Albert, B. Wahren, H. G. Gottlinger, and W. A. Marasco. 1997. Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17. Mol. Med. 3:96-110.
20. Novina, C. D., M. F. Murray, D. M. Dykxhoorn, P. J. Beresford, J. Riess, Sang-Kyung Lee, R. G. Collman, J. Lieberman, P. Shankar, and P. A. Sharp, 2002. SiRNA-directed inhibition of HIV-1 infection. Nat. Med. 8:681-686.
21. Nuffield Council on Bioethics. 1996. Animal-to-human transplants: the ethics of xenotransplantation. Nuffield Council on Bioethics, London, United Kingdom.
22. Ono, A., J. M. Orenstein, and E. O. Freed. 2000. Role of gag matrix domain in targeting human immunodeficiency virus type 1 assembly. J. Virol. 74: 2855-2866.
23. Orlandi, R., D. H. Gussov, P. T. Jones, and G. Winter. 1989. Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86:3833-3837.
24. Paradis, K., G. Langford, Z. Long, W. Heneine, P. Sandstrom, W. M. Switzer, L. E. Chapman, C. Lockey, D. Onions, the XEN 111 Study Group, and E. Otto. 1999. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with liver pig tissue. Science 285:1236-1241.
25. Patience, C., W. M. Switzer, Y. Takeuchi, D. J. Griffiths, M. E. Goward, W. Heneine, J. P. Stoye, and R. A. Weiss. 2001. Multiple groups of novel retroviral genomes in pigs and related species. J. Virol. 75:2771-2775.
26. Patience, C., Y. Takeuchi, and R. A. Weiss. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3:282-286.
27. Phelps, C. J., C. Koike, T. D. Vaught, J. Boone, K. D. Wells, S. Chen, S. Ball, S. M. Specht, I. A. Polejaeva, J. A. Monahan, P. M. Jobst, S. B. Sharma, A. E. Lamborn, A. S. Garst, M. Moore, A. J. Demetris, W. A. Rudert, R. Bottino, S. Bertera, M. Trucco, T. E. Starzl, Y. Dai, and D. L. Ayares. 2003. Production of α-1,3-galactosyltransferase-deficient pigs. Science 299:411-414.
28. Platt, J. L. 2002. Knocking out xenograft rejection. Nat. Biotechnol. 20:231-232.
29. Powell, S. K., M. E. Gates, G. Langford, M. L. Gu, C. Lockey, Z. Long, and E. Otto. 2000. Antiretroviral agents inhibit infection of human cells by porcine endogenous retroviruses. Antimicrob. Agents Chemother. 44:3432-3433.
30. Rein, A., M. R. McClure, N. R. Rice, R. B. Luftig, and A. M. Schultz. 1986. Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc. Natl. Acad. Sci. USA 19:7246-7250.
31. Rossi, J. J. 1999. The application of ribozymes to HIV infection. Curr. Opin. Mol. Ther. 1:316-322.
32. Rother, R. P., W. L. Fodor, J. P. Springhorn, C. W. Birks, E. Setter, M. S. Sandrin, S. P. Squinto, and S. A. Rollins. 1995. A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J. Exp. Med. 182:1345-1355.
33. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
34. Specke, V., S. Rubant, and J. Denner. 2001. Productive infection of human primary cells and cell lines with porcine endogenous retroviruses. Virology 285:177-180.
35. Takeuchi, Y., C. Patience, S. Magre, R. A. Weiss, P. T. Banerjee, P. Le Tissier, and J. P. Stoye. 1998. Host range and interference studies of three classes of pig endogenous retrovirus. J. Virol. 72:9986-9991.
36. Tewari, D., S. L. Goldstein, A. L. Notkins, and P. Zhou. 1998. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication. J. Immunol. 161:2642-2647.
37. Tokuyasu, K. T. 1978. A study of positive staining of ultrathin frozen sections. J. Ultrastruct. Res. 63:287-307.
38. Urlinger, S., U. Baron, M. Thellmann, M. T. Hasan, H. Bujard, and W. Hillen. 2000. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl. Acad. Sci. USA 97:7963-7968.
39. van der Laan, L. J., C. Lockey, B. C. Griffeth, F. S. Frasier, C. A. Wilson, D. E. Onions, B. J. Hering, Z. Long, E. Otto, B. E. Torbett, and D. R. Salomon. 2000. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature 407:90-94.
40. van der Linden, R., B. de Geus, W. Stok, W. Bos, D. van Wassenaar, T. Verrips, and L. Frenken. 2000. Induction of immune responses and molecular cloning of the heavy chain antibody repertoire of Lama glama. J. Immunol. Methods 240:185-195.
41. Weiss, R. A. 1998. Transgenic pigs and virus adaptation. Nature 391:327-328.
42. Yu, X., X. Yuan, Z. Matsuda, T. H. Lee, and M. Essex. 1992. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J. Virol. 66:4966-4971.